Investment in Medcenter

Blue Star Capital plc 17 June 2005 For immediate release 17 June 2005 BLUE STAR CAPITAL PLC ('Blue Star' or 'the Company') Investment in Medcenter Holdings Inc. Blue Star Capital plc (AIM: BLU), the company created to provide seed capital for early stage companies, is pleased to announce it has taken a minority stake in Medcenter Holdings Inc. ('Medcenter'), a leading provider of e-marketing intelligence and relationship marketing solutions to the pharmaceutical industry. Medcenter's clients include a number of the world's top five pharmaceutical companies, in addition to other well-known multi-national pharmaceutical groups. Medcenter focuses on improving communication between the pharmaceutical industry and the medical community with emphasis on increasing the knowledge of physicians and clinicians about the use of pharmaceutical products and about treatments and disease management. Medcenter's solutions comprise programs that augment the marketing activities of pharmaceutical companies by making intensive use of business intelligence, allowing pharmaceutical companies to reach hundreds of thousands of physicians, one at a time in a highly targeted manner. Medcenter is chaired by Michael Fitzgerald who was co-founder and chairman of Gemini Genomics plc, prior to its merger with Sequenom Inc. Michael is also co-founder and chairman of Block Shield Corporation plc. Medcenter operates in more than 10 countries in Latin America, and has subsidiaries in Brazil, Argentina, Mexico and Australia. Blue Star is investing $462,000 in Medcenter, a private company, in return for a minority stake. ENDS For further information: Blue Star Capital plc Tel: 020 7070 7283 Nigel Robertson, Chairman Haresh Kanabar, Chief Executive Panmure Gordon & Co Tel: 020 7459 3600 Jonathan Retter Katherine Roe Buchanan Communications Tel: 020 7466 5000 Mark Court Elly Williamson Notes for editors About Blue Star Capital plc Blue Star Capital plc was formed in 2004 as a vehicle to provide initial seed capital for the development of early stage companies. The Company joined the AIM market of the London Stock Exchange, under the ticker symbol BLU, in October 2004 and has since made significant investments in four newly formed companies: India Outsourcing Services plc, Black Raven Properties plc, Gordian plc and Gasol plc. All of these companies have been admitted to the AIM market and highlight the Company's strategy of making investments across a variety of sectors. Blue Star has a highly capable Board, led by Executive Chairman Nigel Robertson, with significant experience of identifying, evaluating and securing business opportunities and of forming, funding and floating companies. Blue Star intends to achieve capital appreciation from a portfolio of quoted and unquoted investments in businesses that offer strong growth prospects and a defined timeframe to exit. This information is provided by RNS The company news service from the London Stock Exchange MLTMMBBBTA